I-124-CLR1404

· Cellectar Biosciences, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for I-124-CLR1404, covering 2015-09-09 to 2015-09-09. Get the full timeline:

Most recent: Clinical Trial Update: Imaging Trial With I-124-CLR1404 in Patients With Newly Diagnosed or Recurrent Glioblastoma [Phase 2]